Table 3.
Cycle characteristics and clinical outcomes
| Variable | Dynamic score (based on Meseguer’s model) | p value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A− | B+ | B− | C+ | C− | D+ | D− | E | ||
| Total FSH dose (IU) | 2598±1009 | 2394±1009 | 2557±1639 | 2515±1041 | 2416±966 | 2779±1124 | 2507±919 | 2853±1224 | 3105±1626 | 0.002* |
| Number of oocytes aspirated | 12.7±6.5 | 12.5±7.0 | 12.2±6.6 | 10.3±5.4 | 12.4±6.4 | 12.3±7.0 | 11.6±6.5 | 10±5.8 | 9±5.8 | 0.003* |
| Culture media used | ||||||||||
| Vitrolife | 109 (51.7) | 51 (60) | 46 (56.1) | 21 (61.8) | 117 (46.6) | 33 (53.2) | 44 (47.3) | 20 (64.5) | 37 (60.6) | 0.12 |
| Medicult | 102 (48.3) | 34 (40) | 36 (43.9) | 13 (38.2) | 134 (53.4) | 29 (46.8) | 49 (52.7) | 11 (35.5) | 24 (39.4) | |
| Luteal support | ||||||||||
| Prog.* | 97 (46) | 48 (56.5) | 36 (43.9) | 10 (29.4) | 138 (55) | 41 (66.1) | 52 (62.7) | 17 (54.8) | 24 (39.3) | 0.34 |
| Prog+E2** | 114 (54) | 37 (43.5) | 46 (56.1) | 24 (70.6) | 113 (45) | 21 (33.9) | 31 (37.3) | 14 (45.2) | 37 (60.7) | |
| Clinical outcomes | ||||||||||
| Positive bhcg (%) | 31.8 | 48.2 | 43.9 | 20.6 | 48.2 | 38.7 | 43 | 35.5 | 19.7 | 0.00* |
| Implantation rate (%) | 19.4 | 29.4 | 22 | 17.6 | 32.7 | 19.4 | 31.2 | 22.6 | 6.6 | 0.00* |
| Clinical pregnancy rate (%) | 19.4 | 29.4 | 22 | 17.6 | 32.7 | 19.4 | 31.2 | 22.6 | 6.6 | 0.00* |
The data are presented as numbers (percentages) or mean±SD from the mean
*
Prog: progesterone
**
E2: estradiol